Royal Philips Taps Into North American Mammography Market

Julie Ritzer Ross | | Radiology Business | Business Intelligence
Royal Philips Electronics has entered the North American mammography market with the introduction of MicroDose Mammography, a full-field digital mammography (FFDM) solution. The solution is said to administer a lower dose of radiation compared to other FFDM systems, without compromising image quality. According to the company, MicroDose is the only U.S. Food and Drug Administration (FDA)-cleared mammography system that utilizes X-ray photon-counting technology. The latter renders it possible for images to be captured with up to 50% less radiation, while preserving their caliber. Additionally, Philips executives say, the MicroDose photon-counting detector technology also presents opportunities for future breast applications not typical of other FFDM systems, providing the option for continued advancements beyond 2D anatomical breast images in an easy and cost-effective way. Read the press release.

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.